Indonesian Journal of Cancer
Vol 16, No 2 (2022): June

Complete Pathological Response in Stage IV Rectal Carcinoma: Proper Planning and Place is a Key

Deep Lamichhane (Department of Surgical Oncology, Bhaktapur Cancer Hospital, Kathmandu)
Suraj Suwal (Department of Surgical Oncology, Bhaktapur Cancer Hospital, Kathmandu)
Resham Rana (Department of Surgical Oncology, Bhaktapur Cancer Hospital, Kathmandu)
Shweta Baral (Department of Radiation Oncology, Bhaktapur Cancer Hospital, Kathmandu)
Rishikesh Narayan Shrestha (Department of Surgical Oncology, Bhaktapur Cancer Hospital, Kathmandu)



Article Info

Publish Date
29 Jun 2022

Abstract

Introduction: Liver metastasis is frequently encountered in patients with rectal cancer; it can be synchronous or metachronous. Some selected patients can be treated with curative intent using multimodality therapy under the care of a dedicated team in a comprehensive cancer center. However, the treatment is long and tiring for the treating team, the patient, and the relatives. Treatment is difficult to execute in a country like ours with a limited number of cancer centers. We present a patient from a remote village with stage IV disease, who completed all modalities of treatment with a favorable outcome. Case Presentation: A fifty-five-year-old man from a remote village presented to us with a complaint of per rectal bleeding. He was diagnosed with rectal carcinoma with solitary liver metastases. He received multimodality treatment in the form of chemotherapy, radiotherapy, and surgery. He attained a complete pathological response at both primary and metastatic sites.Conclusions: Good outcomes can be achieved in selected stage IV rectal cancer. This requires multimodality treatment and a proper plan, preferably in a comprehensive cancer center 

Copyrights © 2022






Journal Info

Abbrev

ijoc

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health

Description

Indonesian Journal of Cancer is a peer-reviewed and open-access journal. This journal is published quarterly (in March, June, September, and December) by Dharmais Cancer Hospital - National Cancer Center. Submissions are reviewed under a broad scope of topics relevant to experimental and clinical ...